Cite
HARVARD Citation
Blanke, C. et al. (2015). S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors. Oncologist. pp. 1353-1354. [Online].